Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Organogenesis Holdings Inc. | Chief Commercial Officer | Class A Common Stock | 521K | $1.46M | $2.80 | Apr 1, 2024 | Direct |
Organogenesis Holdings Inc. | Chief Commercial Officer | Stock Option (Right to Buy) | 314K | Feb 21, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ORGO | Organogenesis Holdings Inc. | Apr 1, 2024 | 1 | -$5.54K | 4 | Apr 3, 2024 | Chief Commercial Officer |
ORGO | Organogenesis Holdings Inc. | Feb 21, 2024 | 2 | $0 | 4 | Feb 23, 2024 | Chief Commercial Officer |
ORGO | Organogenesis Holdings Inc. | Feb 15, 2024 | 3 | -$84K | 4 | Feb 20, 2024 | Chief Commercial Officer |
ORGO | Organogenesis Holdings Inc. | Apr 1, 2023 | 1 | -$5.13K | 4 | Apr 4, 2023 | Chief Commercial Officer |
ORGO | Organogenesis Holdings Inc. | Feb 22, 2023 | 2 | $0 | 4 | Feb 24, 2023 | Chief Commercial Officer |
ORGO | Organogenesis Holdings Inc. | Feb 15, 2023 | 2 | -$12K | 4 | Feb 17, 2023 | Chief Commercial Officer |
ORGO | Organogenesis Holdings Inc. | Aug 20, 2022 | 2 | $1.18K | 4 | Aug 24, 2022 | Chief Commercial Officer |
ORGO | Organogenesis Holdings Inc. | Apr 1, 2022 | 1 | -$15.6K | 4 | Apr 5, 2022 | Chief Commercial Officer |
ORGO | Organogenesis Holdings Inc. | Feb 15, 2022 | 3 | -$6.22K | 4 | Feb 17, 2022 | Chief Commercial Officer |